Matches in SemOpenAlex for { <https://semopenalex.org/work/W4223916938> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W4223916938 endingPage "106583" @default.
- W4223916938 startingPage "106583" @default.
- W4223916938 abstract "Vancomycin (VAN) causes acute kidney injury as defined by serum creatinine (SCr) increase. Glomerular filtration rate (GFR) is the gold standard for defining kidney function, and SCr is often used as a GFR surrogate; however, SCr changes can lag behind acute functional decline. We sought to define the rate and extent of GFR change for VAN in a translational rat model. Male Sprague Dawley rats received VAN 150 mg/kg/day intravenously (n = 6) or saline (n = 5) once daily followed by an intravenous injection of fluorescein isothiocyanate-sinistrin (FITC-sinistrin) for 3 days. FITC-sinistrin fluorescence was monitored transdermally prior to VAN administration and daily during treatment. GFR was calculated from FITC-sinistrin clearance. A mixed-effects model compared urinary biomarkers and GFRs between treatments and across days of dosing. Urinary biomarkers for injury and GFR were compared between treatment groups and correlated with VAN kidney accumulation. Mean GFR for saline-treated animals was 1.07, 1.20, 1.15 and 1.24 mL/min/100g body weight (b.w.) pre-treatment and at Days 1-3, respectively. VAN-treated rats had lower GFR after treatment (0.457, 0.584 and 0.759 mL/min/100g b.w. on Days 1-3, respectively; P ≤ 0.05). KIM-1 and clusterin were elevated on Day 1 for VAN-treated animals. The relationship between VAN accumulation in the kidney with GFR and biomarkers followed a four-parameter Hill slope (R2 = 0.6 and R2 = 0.9, respectively). Rats receiving VAN had a significant decline in GFR immediately following the first dose, which correlated with increasing VAN concentrations in the kidney and urinary biomarkers." @default.
- W4223916938 created "2022-04-19" @default.
- W4223916938 creator A5022097782 @default.
- W4223916938 creator A5028313744 @default.
- W4223916938 creator A5049257647 @default.
- W4223916938 creator A5073981786 @default.
- W4223916938 date "2022-05-01" @default.
- W4223916938 modified "2023-10-18" @default.
- W4223916938 title "A translational rat model to assess glomerular function changes with vancomycin" @default.
- W4223916938 cites W1602686945 @default.
- W4223916938 cites W2086254942 @default.
- W4223916938 cites W2121721918 @default.
- W4223916938 cites W2129550243 @default.
- W4223916938 cites W2145136986 @default.
- W4223916938 cites W2306327748 @default.
- W4223916938 cites W2482751408 @default.
- W4223916938 cites W2521841512 @default.
- W4223916938 cites W2746653474 @default.
- W4223916938 cites W2940061256 @default.
- W4223916938 cites W2943944245 @default.
- W4223916938 cites W3004863894 @default.
- W4223916938 cites W3188084363 @default.
- W4223916938 doi "https://doi.org/10.1016/j.ijantimicag.2022.106583" @default.
- W4223916938 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35378229" @default.
- W4223916938 hasPublicationYear "2022" @default.
- W4223916938 type Work @default.
- W4223916938 citedByCount "3" @default.
- W4223916938 countsByYear W42239169382023 @default.
- W4223916938 crossrefType "journal-article" @default.
- W4223916938 hasAuthorship W4223916938A5022097782 @default.
- W4223916938 hasAuthorship W4223916938A5028313744 @default.
- W4223916938 hasAuthorship W4223916938A5049257647 @default.
- W4223916938 hasAuthorship W4223916938A5073981786 @default.
- W4223916938 hasBestOaLocation W42239169381 @default.
- W4223916938 hasConcept C126322002 @default.
- W4223916938 hasConcept C126894567 @default.
- W4223916938 hasConcept C134018914 @default.
- W4223916938 hasConcept C159641895 @default.
- W4223916938 hasConcept C185592680 @default.
- W4223916938 hasConcept C190283241 @default.
- W4223916938 hasConcept C2777397205 @default.
- W4223916938 hasConcept C2779476363 @default.
- W4223916938 hasConcept C2780306776 @default.
- W4223916938 hasConcept C2780472472 @default.
- W4223916938 hasConcept C55493867 @default.
- W4223916938 hasConcept C71924100 @default.
- W4223916938 hasConcept C77411442 @default.
- W4223916938 hasConceptScore W4223916938C126322002 @default.
- W4223916938 hasConceptScore W4223916938C126894567 @default.
- W4223916938 hasConceptScore W4223916938C134018914 @default.
- W4223916938 hasConceptScore W4223916938C159641895 @default.
- W4223916938 hasConceptScore W4223916938C185592680 @default.
- W4223916938 hasConceptScore W4223916938C190283241 @default.
- W4223916938 hasConceptScore W4223916938C2777397205 @default.
- W4223916938 hasConceptScore W4223916938C2779476363 @default.
- W4223916938 hasConceptScore W4223916938C2780306776 @default.
- W4223916938 hasConceptScore W4223916938C2780472472 @default.
- W4223916938 hasConceptScore W4223916938C55493867 @default.
- W4223916938 hasConceptScore W4223916938C71924100 @default.
- W4223916938 hasConceptScore W4223916938C77411442 @default.
- W4223916938 hasFunder F4320313823 @default.
- W4223916938 hasFunder F4320332161 @default.
- W4223916938 hasFunder F4320337355 @default.
- W4223916938 hasIssue "5" @default.
- W4223916938 hasLocation W42239169381 @default.
- W4223916938 hasLocation W42239169382 @default.
- W4223916938 hasLocation W42239169383 @default.
- W4223916938 hasOpenAccess W4223916938 @default.
- W4223916938 hasPrimaryLocation W42239169381 @default.
- W4223916938 hasRelatedWork W1564222293 @default.
- W4223916938 hasRelatedWork W1948603161 @default.
- W4223916938 hasRelatedWork W2022369832 @default.
- W4223916938 hasRelatedWork W2050789305 @default.
- W4223916938 hasRelatedWork W2313598751 @default.
- W4223916938 hasRelatedWork W2387860588 @default.
- W4223916938 hasRelatedWork W2411849704 @default.
- W4223916938 hasRelatedWork W2909812024 @default.
- W4223916938 hasRelatedWork W393698729 @default.
- W4223916938 hasRelatedWork W4226212074 @default.
- W4223916938 hasVolume "59" @default.
- W4223916938 isParatext "false" @default.
- W4223916938 isRetracted "false" @default.
- W4223916938 workType "article" @default.